- Insulin glargine2007 | Second Faculty of Medicine
- Insulin glargine: a proven basal insulin analogue2014 | Second Faculty of Medicine
- Improving the metabolic compensation of patients with type 1 diabetes mellitus - a comparison of two treatment algorithms with another glargine2007 | Second Faculty of Medicine
- Pharmacokinetics and metabolism of new long-acting insulin glargine U3002015 | First Faculty of Medicine
- Insulin glargine (Lantus) during unplanned pregnancy in type 1 diabetic patient2006 | Central Library of Charles University
- Insulin glargine (Lantus) during unplanned pregnancy in type 1 diabetic patient2006 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Final Report of the University Hospital Hradec Králové clinical trial Protocol no. EFC11628Publication without faculty affiliation
- Glycaemic Control of Type 2 Diabetics with Insulin Glargine in Everyday Practice Type 2 diabetic patients poorly controlled on insulin detemir therapy benefit from switching to insulin glargine2013 | Second Faculty of Medicine
- Insulin glargine use is not associated with an increased risk of breast cancer compared to NPH insulin and detemir insulin2020 | Second Faculty of Medicine
- Expert Opinion on the Therapeutic Use of the Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective2020 | First Faculty of Medicine
- Insulin glargine 300 IU/mL vs insulin degludec or sometimes it is more difficult to choose from two excellent options than from two bad ones2020 | First Faculty of Medicine
- The study ORIGIN: Insulin glargine has become the reference basal analogue with proven cardiovascular safety2013 | Second Faculty of Medicine
- Long-term evaluation of patients with type 1 diabetes mellitus treated with insulin glargine2009 | Central Library of Charles University
- Long-term evaluation of patients with type 1 diabetes mellitus treated with insulin glargine2009 | Faculty of Medicine in Pilsen
- Long-term evaluation of patients with type 1 diabetes mellitus treated with insulin glargine2009 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice - safety and efficacy in basal bolus regimen)2014 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Insulin glargine 300 U/ml (Toujeo) - an optimal basal insulin for a geriatric patient treated for type 1 diabetes mellitus2018 | Second Faculty of Medicine
- RESOLUTE Study in the Czech Republic: insulin glargine improves the compensation of type 2 diabetes in patients with unsatisfactory results of therapy with a combination of insulin detemir and oral antidiabetics. Results of the non-intervention RESOLUTE Project in the Czech Republic2013 | Second Faculty of Medicine
- Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis2023 | First Faculty of Medicine
- Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial2008 | Central Library of Charles University, Second Faculty of Medicine
- POET2 registry: Comparison of annual direct medical costs of treating type 2 diabetes after addition of insulin NPH or insulin glargine to oral antidiabetic therapy in the Czech Republic2015 | Second Faculty of Medicine
- Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: The COBIN2 study2014 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Comparison of insulin degludec with insulin glargine in insulin-naive subjects with type 2 diabetes: a 2-year randomized, treat-to-target trial2013 | Second Faculty of Medicine
- Insulin Glargine 300 Units/mL Effectiveness in Patients with T2DM Uncontrolled by Basal Insulin in Real-Life Settings in the Czech Republic2020 | First Faculty of Medicine
- The use of insulin glargine 300 U/mL (Toujeo 300 U/mL) in a pregnant patient with the type 2 diabetes mellitus2016 | First Faculty of Medicine
- Self-titration of basal insulin glargine in type 2. diabetes mellitus patient2007 | Central Library of Charles University, Third Faculty of Medicine
- Inzulin glargine 300 IU/ml2015 | First Faculty of Medicine
- Practical contribution of the insulin analogue glargine 300 U/ml2016 | Second Faculty of Medicine
- The place of insulin glargine in the complex intervention of developed complications of type 2 diabetes mellitus2004 | Second Faculty of Medicine
- Efficacy of insulin glargine 300 U/ml in patients with type 2 diabetes insufficiently compensated by basal insulin therapy in the conditions of routine clinical practice in the Czech Republic2021 | First Faculty of Medicine